David M Kaye - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David M Kaye

Showing results (91-100 of 418) with videos related to

Pageof 42

Sort By:

Heart, Lung & Circulation|July 16, 2025

Riding the Impella Wave in Cardiogenic Shock: Is it Time for Australia to Get on Board?Dion Stub, Riley J Batchelor, Jason E Bloom, et al.

Internal Medicine Journal|August 8, 2017

Extended release oral milrinone as an adjunct to heart failure therapyShane Nanayakkara, Peter Bergin, Vivian Mak, et al.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 6, 2025

Left Atrial Unloading in Heart Failure With Preserved Ejection Fraction: In-Vitro Study of Interatrial Shunting and Continuous Flow PumpingNina Langer, Andrew F Stephens, David M Kaye, et al.

Circulation. Heart Failure|September 19, 2013

Cellular reprogramming: a new avenue to cardiac regeneration?Anthony J White, Deevina Arasaratnam, David A Elliott, et al.

ESC Heart Failure|September 9, 2020

Identification of physiologic treatment targets with favourable haemodynamic consequences in heart failure with preserved ejection fractionDavid M Kaye, Melissa Byrne, Justin Mariani, et al.

Circulation. Cardiovascular Quality and Outcomes|October 17, 2022

Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection FractionJennifer Zhou, Danny Liew, David M Kaye, et al.

Journal of Cardiac Failure|September 4, 2012

Hemodynamic determinants of the abnormal cardiopulmonary exercise response in heart failure with preserved left ventricular ejection fractionMicha T Maeder, Bruce R Thompson, Nay Htun, et al.

Echocardiography (Mount Kisco, N.Y.)|March 3, 2015

Accuracy of Echocardiographic Cardiac Index Assessment in Subjects with Preserved Left Ventricular Ejection FractionMicha T Maeder, Sofie Karapanagiotidis, Elizabeth M Dewar, et al.

European Heart Journal. Case Reports|December 13, 2024

Fulminant eosinophilic myocarditis and refractory ventricular arrhythmias requiring mechanical circulatory support: a case reportClaudia Brick, Angeline Leet, Hui Tay, et al.

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 1, 2009

Changes in right ventricular function during continuous-flow left ventricular assist device support [corrected]Micha T Maeder, Angeline Leet, Andrew Ross, et al.

Pageof 42

Search research articles

Showing results (91-100 of 418) with videos related to

Sort By:

Pageof 42

Heart, Lung & Circulation|July 16, 2025

Riding the Impella Wave in Cardiogenic Shock: Is it Time for Australia to Get on Board?Dion Stub, Riley J Batchelor, Jason E Bloom, et al.

Internal Medicine Journal|August 8, 2017

Extended release oral milrinone as an adjunct to heart failure therapyShane Nanayakkara, Peter Bergin, Vivian Mak, et al.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)|May 6, 2025

Left Atrial Unloading in Heart Failure With Preserved Ejection Fraction: In-Vitro Study of Interatrial Shunting and Continuous Flow PumpingNina Langer, Andrew F Stephens, David M Kaye, et al.

Circulation. Heart Failure|September 19, 2013

Cellular reprogramming: a new avenue to cardiac regeneration?Anthony J White, Deevina Arasaratnam, David A Elliott, et al.

ESC Heart Failure|September 9, 2020

Identification of physiologic treatment targets with favourable haemodynamic consequences in heart failure with preserved ejection fractionDavid M Kaye, Melissa Byrne, Justin Mariani, et al.

Circulation. Cardiovascular Quality and Outcomes|October 17, 2022

Cost-Effectiveness of Empagliflozin in Patients With Heart Failure and Preserved Ejection FractionJennifer Zhou, Danny Liew, David M Kaye, et al.

Journal of Cardiac Failure|September 4, 2012

Hemodynamic determinants of the abnormal cardiopulmonary exercise response in heart failure with preserved left ventricular ejection fractionMicha T Maeder, Bruce R Thompson, Nay Htun, et al.

Echocardiography (Mount Kisco, N.Y.)|March 3, 2015

Accuracy of Echocardiographic Cardiac Index Assessment in Subjects with Preserved Left Ventricular Ejection FractionMicha T Maeder, Sofie Karapanagiotidis, Elizabeth M Dewar, et al.

European Heart Journal. Case Reports|December 13, 2024

Fulminant eosinophilic myocarditis and refractory ventricular arrhythmias requiring mechanical circulatory support: a case reportClaudia Brick, Angeline Leet, Hui Tay, et al.

The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 1, 2009

Changes in right ventricular function during continuous-flow left ventricular assist device support [corrected]Micha T Maeder, Angeline Leet, Andrew Ross, et al.

Pageof 42